Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
Gespeichert in:
| Veröffentlicht in: | Blood 2008, Vol.112 (10), p.3889-3894 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3894 |
|---|---|
| container_issue | 10 |
| container_start_page | 3889 |
| container_title | Blood |
| container_volume | 112 |
| creator | KOBE, Carsten DIETLEIN, Markus WECKESSER, Matthias LORENZ, Reinhard SCHRECKENBERGER, Mathias BARES, Roland ETCH, Hans T MUELLER, Rolf-Peter FUCHS, Michael BORCHMANN, Peter SCHICHA, Harald DIEHL, Volker FRANKLIN, Jeremy ENGERT, Andreas MARKOVA, Jana LOHRI, Andreas AMTHAUER, Holger KLUTMANN, Susanne KNAPP, Wolfram H ZIJLSTRA, Josee M BOCKISCH, Andreas |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_20845652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20845652</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_208456523</originalsourceid><addsrcrecordid>eNqNjstOxDAMRSMEEuXxD96wrJTptMOwRqBZsmA_shq3MeSlOFPUH-S7iGA-gJWvr8-RfKGazdDtW607fakarfWu7Z8eN9fqRuRD602_7YZGfb9F4ZJjAPIswjWU6OOcMdkVLAogWJ4tBJqx8EKQMhkef-OC7kQwxVzLqtCfX1fC7FbI5DDJGagyhSLwxcXWi7A5oQPDQlgRnAplmDhLaR0HgtGSj8VS_WMFDoBmwTCSaaXgTHCIZv6stVt9stHjnbqa0Andn-etenh9eX8-tAllRDflKrMcU2aPeT12et8Pu6Hb_pf7AasAb_8</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>KOBE, Carsten ; DIETLEIN, Markus ; WECKESSER, Matthias ; LORENZ, Reinhard ; SCHRECKENBERGER, Mathias ; BARES, Roland ; ETCH, Hans T ; MUELLER, Rolf-Peter ; FUCHS, Michael ; BORCHMANN, Peter ; SCHICHA, Harald ; DIEHL, Volker ; FRANKLIN, Jeremy ; ENGERT, Andreas ; MARKOVA, Jana ; LOHRI, Andreas ; AMTHAUER, Holger ; KLUTMANN, Susanne ; KNAPP, Wolfram H ; ZIJLSTRA, Josee M ; BOCKISCH, Andreas</creator><creatorcontrib>KOBE, Carsten ; DIETLEIN, Markus ; WECKESSER, Matthias ; LORENZ, Reinhard ; SCHRECKENBERGER, Mathias ; BARES, Roland ; ETCH, Hans T ; MUELLER, Rolf-Peter ; FUCHS, Michael ; BORCHMANN, Peter ; SCHICHA, Harald ; DIEHL, Volker ; FRANKLIN, Jeremy ; ENGERT, Andreas ; MARKOVA, Jana ; LOHRI, Andreas ; AMTHAUER, Holger ; KLUTMANN, Susanne ; KNAPP, Wolfram H ; ZIJLSTRA, Josee M ; BOCKISCH, Andreas</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><language>eng</language><publisher>Washington, DC: Americain Society of Hematology</publisher><subject>Biological and medical sciences ; Hematologic and hematopoietic diseases ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences</subject><ispartof>Blood, 2008, Vol.112 (10), p.3889-3894</ispartof><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20845652$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>KOBE, Carsten</creatorcontrib><creatorcontrib>DIETLEIN, Markus</creatorcontrib><creatorcontrib>WECKESSER, Matthias</creatorcontrib><creatorcontrib>LORENZ, Reinhard</creatorcontrib><creatorcontrib>SCHRECKENBERGER, Mathias</creatorcontrib><creatorcontrib>BARES, Roland</creatorcontrib><creatorcontrib>ETCH, Hans T</creatorcontrib><creatorcontrib>MUELLER, Rolf-Peter</creatorcontrib><creatorcontrib>FUCHS, Michael</creatorcontrib><creatorcontrib>BORCHMANN, Peter</creatorcontrib><creatorcontrib>SCHICHA, Harald</creatorcontrib><creatorcontrib>DIEHL, Volker</creatorcontrib><creatorcontrib>FRANKLIN, Jeremy</creatorcontrib><creatorcontrib>ENGERT, Andreas</creatorcontrib><creatorcontrib>MARKOVA, Jana</creatorcontrib><creatorcontrib>LOHRI, Andreas</creatorcontrib><creatorcontrib>AMTHAUER, Holger</creatorcontrib><creatorcontrib>KLUTMANN, Susanne</creatorcontrib><creatorcontrib>KNAPP, Wolfram H</creatorcontrib><creatorcontrib>ZIJLSTRA, Josee M</creatorcontrib><creatorcontrib>BOCKISCH, Andreas</creatorcontrib><title>Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma</title><title>Blood</title><subject>Biological and medical sciences</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNjstOxDAMRSMEEuXxD96wrJTptMOwRqBZsmA_shq3MeSlOFPUH-S7iGA-gJWvr8-RfKGazdDtW607fakarfWu7Z8eN9fqRuRD602_7YZGfb9F4ZJjAPIswjWU6OOcMdkVLAogWJ4tBJqx8EKQMhkef-OC7kQwxVzLqtCfX1fC7FbI5DDJGagyhSLwxcXWi7A5oQPDQlgRnAplmDhLaR0HgtGSj8VS_WMFDoBmwTCSaaXgTHCIZv6stVt9stHjnbqa0Andn-etenh9eX8-tAllRDflKrMcU2aPeT12et8Pu6Hb_pf7AasAb_8</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>KOBE, Carsten</creator><creator>DIETLEIN, Markus</creator><creator>WECKESSER, Matthias</creator><creator>LORENZ, Reinhard</creator><creator>SCHRECKENBERGER, Mathias</creator><creator>BARES, Roland</creator><creator>ETCH, Hans T</creator><creator>MUELLER, Rolf-Peter</creator><creator>FUCHS, Michael</creator><creator>BORCHMANN, Peter</creator><creator>SCHICHA, Harald</creator><creator>DIEHL, Volker</creator><creator>FRANKLIN, Jeremy</creator><creator>ENGERT, Andreas</creator><creator>MARKOVA, Jana</creator><creator>LOHRI, Andreas</creator><creator>AMTHAUER, Holger</creator><creator>KLUTMANN, Susanne</creator><creator>KNAPP, Wolfram H</creator><creator>ZIJLSTRA, Josee M</creator><creator>BOCKISCH, Andreas</creator><general>Americain Society of Hematology</general><scope>IQODW</scope></search><sort><creationdate>2008</creationdate><title>Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma</title><author>KOBE, Carsten ; DIETLEIN, Markus ; WECKESSER, Matthias ; LORENZ, Reinhard ; SCHRECKENBERGER, Mathias ; BARES, Roland ; ETCH, Hans T ; MUELLER, Rolf-Peter ; FUCHS, Michael ; BORCHMANN, Peter ; SCHICHA, Harald ; DIEHL, Volker ; FRANKLIN, Jeremy ; ENGERT, Andreas ; MARKOVA, Jana ; LOHRI, Andreas ; AMTHAUER, Holger ; KLUTMANN, Susanne ; KNAPP, Wolfram H ; ZIJLSTRA, Josee M ; BOCKISCH, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_208456523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KOBE, Carsten</creatorcontrib><creatorcontrib>DIETLEIN, Markus</creatorcontrib><creatorcontrib>WECKESSER, Matthias</creatorcontrib><creatorcontrib>LORENZ, Reinhard</creatorcontrib><creatorcontrib>SCHRECKENBERGER, Mathias</creatorcontrib><creatorcontrib>BARES, Roland</creatorcontrib><creatorcontrib>ETCH, Hans T</creatorcontrib><creatorcontrib>MUELLER, Rolf-Peter</creatorcontrib><creatorcontrib>FUCHS, Michael</creatorcontrib><creatorcontrib>BORCHMANN, Peter</creatorcontrib><creatorcontrib>SCHICHA, Harald</creatorcontrib><creatorcontrib>DIEHL, Volker</creatorcontrib><creatorcontrib>FRANKLIN, Jeremy</creatorcontrib><creatorcontrib>ENGERT, Andreas</creatorcontrib><creatorcontrib>MARKOVA, Jana</creatorcontrib><creatorcontrib>LOHRI, Andreas</creatorcontrib><creatorcontrib>AMTHAUER, Holger</creatorcontrib><creatorcontrib>KLUTMANN, Susanne</creatorcontrib><creatorcontrib>KNAPP, Wolfram H</creatorcontrib><creatorcontrib>ZIJLSTRA, Josee M</creatorcontrib><creatorcontrib>BOCKISCH, Andreas</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KOBE, Carsten</au><au>DIETLEIN, Markus</au><au>WECKESSER, Matthias</au><au>LORENZ, Reinhard</au><au>SCHRECKENBERGER, Mathias</au><au>BARES, Roland</au><au>ETCH, Hans T</au><au>MUELLER, Rolf-Peter</au><au>FUCHS, Michael</au><au>BORCHMANN, Peter</au><au>SCHICHA, Harald</au><au>DIEHL, Volker</au><au>FRANKLIN, Jeremy</au><au>ENGERT, Andreas</au><au>MARKOVA, Jana</au><au>LOHRI, Andreas</au><au>AMTHAUER, Holger</au><au>KLUTMANN, Susanne</au><au>KNAPP, Wolfram H</au><au>ZIJLSTRA, Josee M</au><au>BOCKISCH, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma</atitle><jtitle>Blood</jtitle><date>2008</date><risdate>2008</risdate><volume>112</volume><issue>10</issue><spage>3889</spage><epage>3894</epage><pages>3889-3894</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><cop>Washington, DC</cop><pub>Americain Society of Hematology</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2008, Vol.112 (10), p.3889-3894 |
| issn | 0006-4971 1528-0020 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_20845652 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Biological and medical sciences Hematologic and hematopoietic diseases Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences |
| title | Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A30%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Positron%20emission%20tomography%20has%20a%20high%20negative%20predictive%20value%20for%20progression%20or%20early%20relapse%20for%20patients%20with%20residual%20disease%20after%20first-line%20chemotherapy%20in%20advanced-stage%20Hodgkin%20lymphoma&rft.jtitle=Blood&rft.au=KOBE,%20Carsten&rft.date=2008&rft.volume=112&rft.issue=10&rft.spage=3889&rft.epage=3894&rft.pages=3889-3894&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E20845652%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |